|
Assessing The National Pharmacare Report
Tuesday, March 19th, 2019
The lack of clarity in the scope of a national formulary and associated listing requirements for public insurance also leaves the future role for private insurance companies largely undefined. If the formulary is comprehensive and the listing agreements binding, then there may be only a minor role for private drug insurance. If, however, the formulary covers only essential medicines and provinces retain autonomy in listing decisions, the role of private insurance would remain largely unchanged.
Tags: budget, featured, Health, ideology, jurisdiction, mental Health, pharmaceutical
Posted in Health Policy Context | No Comments »
Recent Comments